Skip to main content

Our corporate governance guidelines help us to create long-term value not only for our shareholders, but also for all of our other stakeholders, including employees, customers, partners, suppliers and patients.

You are invited to review the guidelines, rules and principles under which we conduct our business.

Code of Business Conduct

Our Code of Business Conduct lays out a clear set of principles to guide us as we work to provide high-quality and reliable products for people in need of healthcare. These principles have helped us to shape a robust, company-wide philosophy to be responsible for people, planet and profit simultaneously. We feel a strong sense of responsibility to all of our stakeholders – our employees, customers and suppliers, shareholders, and society at large.

The Centrient Pharmaceuticals Code of Business Conduct oversees, among other things:

  • Trade control compliance
  • Competition law compliance
  • Anti-bribery and corruption compliance
  • Data privacy compliance
  • Code of Conduct for Information Security
  • Centrient Pharmaceuticals Safety Health and Environment Policy
  • Centrient Pharmaceuticals Supplier Code of Conduct

Raise a concern

We encourage our employees and other stakeholders to raise concerns about suspected violations of the Code of Business Conduct. Our company's various reporting mechanisms are listed below:

Telephone: +31 (0)15 279 3485

E-mail (not anonymous): alert@centrient.com

Letter: Please address letters to Centrient Pharmaceuticals’ Risk and Compliance Director, Weena 798A, 3014 DA, Rotterdam, the Netherlands

Regulatory Affairs

Our Regulatory Affairs team makes sure our products are approved for sale by the relevant regulatory authorities around the world and comply with the highest quality standards. Centrient Pharmaceuticals has been granted more than 500 marketing authorisations in multiple countries in Europe and beyond, based on Centrient's finished dosage form registration dossiers presented in the Common Technical Document (CTD) format. Moreover, we own more than 100 active pharmaceutical ingredient (API) dossiers for global registrations – for example, Drug Master Files (DMF) and Certificate of Suitability (CEP) dossiers – to enable our partners and customers to market the finished dosage forms we make and supply globally.

More widely, the team plays an important role in helping to maintain and improve the quality of medicines worldwide by donating reference standards for APIs and impurities to the world’s two leading pharmacopoeias, the European Pharmacopoeia and the United States Pharmacopeia, and being part of an expert group involved in formulating antibiotic monographs for the European Pharmacopoeia.

As a member of the European Chemical Industry Council (CEFIC), we also provide our views regarding new and updated regulations and guidelines via the Active Pharmaceutical Ingredients Committee, a sector-wide group overseen by the Council.

Our leadership

read more

Our values

read more

Our promise

read more
sustainability report